Malaria transmission-blocking vaccines—how can their development be supported?

Malaria is a disease of poor countries. The development of malaria vaccines requires considerable investment, for which there is little commercial interest, particularly for transmission-blocking vaccines that have the public health objective of protecting communities from the spread of malaria rather than protecting individuals from the disease. Here, Carter et al . summarize the report of a committee of experts on the relevance and prospects for these vaccines.